Mercy Bariatrics Now Offers ReShape Non-surgical Weight Loss Procedure
Mercy Bariatrics has added a new procedure to their program: the ReShape® Integrated Dual Balloon System, an FDA approved, non-surgical weight loss procedure for people with mild to moderate obesity. It is now available at Mercy Fitzgerald Hospital in Darby and Mercy Philadelphia Hospital in West Philadelphia. The dual balloon system provides a new option for adults with a BMI of 30-40 and a related health condition who haven’t succeeded at diet and exercise alone and do not want or do not qualify for bariatric surgery.
“For years a significant gap has existed in treatment options for obesity with limited, effective therapies available,” said Prashanth Ramachandra, MD, Chair of the Surgery Departments of Mercy Fitzgerald and Mercy Philadelphia Hospitals and bariatric and general surgeon. “We often see patients who are clinically obese and in desperate need of medical intervention to help them lose weight, when diet and exercise alone have failed and surgery is not an option. The dual balloon provides this group of ‘in-between’ patients with access to a non-surgical, reversible option to encourage new habits and lasting results.”
The dual balloon is inserted in the stomach during a short outpatient procedure, where it remains for six months, serving as built-in portion control so people may feel full and less hungry. It does not change or alter the natural anatomy of the stomach in any way.
During this time and for the six months after removal, patients receive frequent in-office diet and exercise coaching sessions and access to the ReShape Patient Portal, an online support resource that provides tools and information to help patients track weight loss, diet, and exercise and an on-line community where they can interact with each other.
This is all in addition to the post-operative services that the Mercy Bariatrics Program provides, including 24/7 access to the bariatric surgeons and coordinator, and bariatric support group classes.
More than 78 million adults in the U.S. are obese. In June 2013, the American Medical Association officially classified obesity as a disease. Clinically defined as having a Body Mass Index (BMI) of more than 30, obesity can lead to numerous, serious health complications including heart disease, stroke, type 2 diabetes and certain types of cancer.
In an FDA clinical study of 326 patients conducted at eight sites in the US, patients with the dual balloons experienced 2.3 times more excess weight loss at six months compared to those who had the diet and exercise program alone. In the clinical trial, patients lost up to 72 pounds in 12 months.